ALILAZTINI
- Strength
- 80mg
- Manufacturer
- Availability
- Available to source
Ask for price
ALILAZTINI 80mg — 90片
Need assistance?
Our multilingual healthcare support team can help with availability, shipping and ordering.
Chat on WhatsApp
Scan for WeChat
About this medicine
This product is a kinase inhibitor indicated, in combination with amivantamab, for the treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 L858R substitution mutations.
This information is provided for reference only and is not medical advice. Always consult a qualified healthcare professional.
Related medicines
